New
Clear30 is awarded a $3 million grant from NIH for cannabis use disorder.
×
Clear30
HomeClear30 for Universities
Colleges & Universities
Screening, education, and intervention
Employers
Confidential support for your workforce
Insurers & Health Systems
Reach members before it becomes a claim
States & Public Health
Free and confidential, statewide
Our researchNewsroom
Start your Clear30 now
Clear30
for
Payers & Health Systems

You screen for it.
Then there is
nowhere to refer.

A positive cannabis screen has no obvious next step short of a behavioral health referral most members will never accept. Clear30 is the step in between, at digital cost.
Book a demo
Fifteen minutes with your clinical team.
73%
less cannabis use
From 27 days a month down to 3
88%
improved mental health
Reported at the end of their 30 days
90%
would recommend it
To someone else in the same spot
My members, this month
Dana Whitfield
Dana Whitfield
Benefits Director · Northwind Logistics
The Clear30 app

The cost is already in your book. The code rarely is.

Regular cannabis use drives utilization long before anyone is diagnosed with cannabis use disorder.
Higher utilization
More ED visits, more primary care encounters, and more long-term cost, attributed to whatever presented that day.
Co-occurring complexity
Anxiety, depression, and psychosis risk climb with daily high-potency use, making every other condition harder and more expensive to manage.
EAP and BH strain
Behavioral health capacity is the scarcest resource you have, and cannabis-related need arrives there last and least appropriately.
9.6%
of past-year cannabis users received any substance use treatment. The other 90% are still generating claims. NSDUH (2023)

A referral destination that members actually accept

No prior auth, no waitlist, no network capacity to build.
1
Add it to the pathway
A positive screen or an SBIRT conversation ends in a code instead of a dead end. Care managers, PCPs, and EAP can all refer into it.
2
Members self-direct
They pick a goal, from tracking use to quitting, with no intake and no diagnosis required. That is why they engage rather than no-show.
3
Escalate what needs it
The program surfaces higher-severity users and routes them into your network, so your clinical capacity goes to the people who need it.

Stepped care, starting at digital cost.

Outcomes equivalent to more intensive interventions, at a fraction of the per-member cost, with clinical escalation built in rather than bolted on.
Population-wide access with no capacity constraint
Severity signal to prioritize your clinical resources
Aggregate, de-identified reporting for evaluation

Evidence your clinical team will accept

Developed with the people who wrote the standards for addiction treatment.
67%
fewer days of use
From 27 days a month down to 9.
88%
report improved mental health
After their first 30 days in the program.
89%
saw positive results
Improvement on at least one measure.
For insurers & health systems

Give a positive screen somewhere to go

Book fifteen minutes with your clinical and benefits teams. We will walk through the pathway, the evidence, and the contracting.
📅
Book a demo
The Clear30 app
Day 1, didn’t smoke
Use down 79%
Clear30
The #1 app for a clearer relationship with cannabis.
© 2026 Clear30. Research references available on request.